Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Ghio

Showing results (131-140 of 264) with videos related to

Pageof 27
Sort By:
Acta Cardiologica|January 7, 2020
Iron deficiency in pulmonary arterial hypertension: prevalence and potential usefulness of oral supplementationStefano Ghio, Federico Fortuni, Anna Clizia Capettini, et al.
European Journal of Heart Failure|September 8, 2012
Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) studyJehu Mathew, Ronit Katz, Martin St John Sutton, et al.
Heart and Vessels|November 8, 2013
Mitral and aortic valve sclerosis/calcification and carotid atherosclerosis: results from 1065 patientsAndrea Rossi, Pompilio Faggiano, Alexandra E Amado, et al.
International Journal of Cardiology|June 16, 2018
Dobutamine stress echocardiography in pulmonary arterial hypertensionStefano Ghio, Federico Fortuni, Alessandra Greco, et al.
Heart Failure Reviews|September 20, 2023
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapyFrank L Dini, Erberto Carluccio, Stefano Ghio, et al.
European Journal of Preventive Cardiology|September 11, 2019
The prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy: An updated meta-analysisFederico Fortuni, Filippo Angelini, Raffaele Abete, et al.
Giornale Italiano Di Cardiologia (2006)|December 1, 2017
[Oral combination therapy for the treatment of patients with pulmonary arterial hypertension: what evidence from long-term studies?]Beatrice Pezzuto, Roberto Badagliacca, Roberto Poscia, et al.
Pacing and Clinical Electrophysiology : PACE|August 8, 2009
Relevance of echocardiographic evaluation of right ventricular function in patients undergoing cardiac resynchronization therapyLea Scuteri, Roberto Rordorf, Nina Ajmone Marsan, et al.
European Journal of Heart Failure|June 22, 2012
Left ventricular systolic dysfunction associated with pulmonary hypertension riociguat trial (LEPHT): rationale and designStefano Ghio, Diana Bonderman, Stephan B Felix, et al.
International Journal of Cardiology|May 18, 2012
Aortic valve sclerosis is a marker of atherosclerosis independently of traditional clinical risk factors. Analysis in 712 patients without ischemic heart diseaseAndrea Rossi, Pompilio Faggiano, Alexandra E Amado, et al.
Pageof 27

Showing results (131-140 of 264) with videos related to

Sort By:
Pageof 27
Acta Cardiologica|January 7, 2020
Iron deficiency in pulmonary arterial hypertension: prevalence and potential usefulness of oral supplementationStefano Ghio, Federico Fortuni, Anna Clizia Capettini, et al.
European Journal of Heart Failure|September 8, 2012
Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) studyJehu Mathew, Ronit Katz, Martin St John Sutton, et al.
Heart and Vessels|November 8, 2013
Mitral and aortic valve sclerosis/calcification and carotid atherosclerosis: results from 1065 patientsAndrea Rossi, Pompilio Faggiano, Alexandra E Amado, et al.
International Journal of Cardiology|June 16, 2018
Dobutamine stress echocardiography in pulmonary arterial hypertensionStefano Ghio, Federico Fortuni, Alessandra Greco, et al.
Heart Failure Reviews|September 20, 2023
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapyFrank L Dini, Erberto Carluccio, Stefano Ghio, et al.
European Journal of Preventive Cardiology|September 11, 2019
The prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy: An updated meta-analysisFederico Fortuni, Filippo Angelini, Raffaele Abete, et al.
Giornale Italiano Di Cardiologia (2006)|December 1, 2017
[Oral combination therapy for the treatment of patients with pulmonary arterial hypertension: what evidence from long-term studies?]Beatrice Pezzuto, Roberto Badagliacca, Roberto Poscia, et al.
Pacing and Clinical Electrophysiology : PACE|August 8, 2009
Relevance of echocardiographic evaluation of right ventricular function in patients undergoing cardiac resynchronization therapyLea Scuteri, Roberto Rordorf, Nina Ajmone Marsan, et al.
European Journal of Heart Failure|June 22, 2012
Left ventricular systolic dysfunction associated with pulmonary hypertension riociguat trial (LEPHT): rationale and designStefano Ghio, Diana Bonderman, Stephan B Felix, et al.
International Journal of Cardiology|May 18, 2012
Aortic valve sclerosis is a marker of atherosclerosis independently of traditional clinical risk factors. Analysis in 712 patients without ischemic heart diseaseAndrea Rossi, Pompilio Faggiano, Alexandra E Amado, et al.
Pageof 27